David Katz

It is a good bit above what the Street was looking for. They raised their fundamental outlook.

However, most evidence suggests that the metabolic effects of sucrose and HFCS are pretty similar. What makes HFCS such a hazard is that corn growth is highly subsidized in the United States, so HFCS is very inexpensive - and thus a tempting additive to many foods.

There are far more satisfying explanations for epidemic obesity. We have more calories available per capita per day than ever before in history. And more and more of those calories are packaged in highly processed, flavor-enhanced, processed foods.

Our feeling has been and continues to be that there are going to be lots of home runs and strikeouts in technology. It's not a quarter-to-quarter-assured industry.

We think the stock is going to do very well. We like that industry. We think you have 40 percent upside on Applied.

Without any question, inflation will one day be out there. Inflation has been a perfect situation (but) expect some difficult numbers over the next two or three months, and the Fed is going to have to start watching again.

Not surprisingly, the disclosure of information about unsuspected paternity comes with potentially devastating effects.

The foundation believes the merger is not in their best interest and they have a big economic and equity interest.

Don't get fooled that way. Most people need to spend more time, especially when the market is going to be volatile, to study companies relative to industry norms and historic norms for valuation.

You don't know who's going to win until they actually win and by the time stocks react to that, it's too late.

We think the semiconductor companies are starting to look very interesting, if you have a 12-month time horizon. Our favorite is Advanced Micro Devices, secondarily Intel at 25, 26 is interesting. We think (Advanced Micro), however, can go up about 50 to 100 percent,

We think that the rhetoric is going to be fairly negative and that is going to push prices of drug companies modestly lower over the short term. That's a very good time to be adding to positions. We think a year or two from now, not a lot is going to change and the drug companies are good growth businesses at more reasonable prices.

We think this is the cutting edge that's going to define how our products shape next generation networks, ... What happens here will be happening in other industries in a very short period of time.

They've grown earnings at about 15 percent a year for the last decade, ... They're always gaining market share. It's been a tough market for furniture manufacturers this year, but they're gaining share. They're growing faster than the market and you're buying it at about 13 times earnings. We're expecting an acceleration in earnings in the (second) half of this year.

Obesity is arguably the gravest public health threat in the United States today.

We would try not to trade on a day-to-day basis,

The market will take its cues from political events, Afghanistan events, ... stocks should start to trade higher.

On the Boston Scientific side the vote will be approved.

There is a great likelihood the merger won't happen if the families vote against the merger plus the foundation,

It's very important to remember that with the Dow at 8,000 -- with the market at about 22 or 23 times earnings -- there's just very little margin for safety. If anything in the economy, anything with inflation, anything with a world event goes wrong, you're going to see more downside than you normally would.

People who say obesity has been hyped are wrong.

I think Jackson and colleagues are likely to be wrong.

Looks like it's now going to be a race. Anybody that does not have a partner is going to be looking fast and hard to find a partner. a lot of people have had discussions over the last few years -- those discussions are going to accelerate.

January has historically been a better month in the market overall, especially pronounced in terms of companies that have had poor prior years -- after tax selling abates, they're due for a very strong bounce in January.

If you look at long-term trends in the markets the last 20, 30, 40 years, they are typically seven- to-10-year cycles where large caps do well, and then small caps do well,